Property name | Tool | Property value |
---|---|---|
Molecular weight (g/mol) | RDKit | 0 |
Log P | RDKit | 0 |
Topological polar surface area (Å2) | RDKit | |
Number of hydrogen bond acceptors | RDKit | |
Number of hydrogen bond donors | RDKit | |
Number of carbon atoms | RDKit | |
Number of heavy atoms | RDKit | |
Number of heteroatoms | RDKit | |
Number of nitrogen atoms | RDKit | |
Number of sulfur atoms | RDKit | |
Number of chiral carbon atoms | RDKit | |
Stereochemical complexity | RDKit | 0 |
Number of sp hybridized carbon atoms | RDKit | |
Number of sp2 hybridized carbon atoms | RDKit | |
Number of sp3 hybridized carbon atoms | RDKit | |
Shape complexity | RDKit | |
Number of rotatable bonds | RDKit | |
Number of aliphatic carbocycles | RDKit | |
Number of aliphatic heterocycles | RDKit | |
Number of aliphatic rings | RDKit | |
Number of aromatic carbocycles | RDKit | |
Number of aromatic heterocycles | RDKit | |
Number of aromatic rings | RDKit | |
Total number of rings | RDKit | |
Number of saturated carbocycles | RDKit | |
Number of saturated heterocycles | RDKit | |
Number of saturated rings | RDKit | |
Number of Smallest Set of Smallest Rings (SSSR) | RDKit |
Property name | Tool | Property value |
---|---|---|
Number of Lipinski’s rule of 5 violations | RDKit | 2 |
Lipinski’s rule of 5 | RDKit | Failed |
Number of Ghose rule violations | RDKit | 1 |
Ghose rule | RDKit | Failed |
Veber rule | RDKit | Bad |
Egan rule | RDKit | Bad |
GSK 4/400 rule | RDKit | Good |
Pfizer 3/75 rule | RDKit | Good |
Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.24 |
Property name | Tool | Property value |
---|---|---|
Bioavailability score | SwissADME | 0.17 |
Solubility class [ESOL] | SwissADME | Highly soluble |
Solubility class [Silicos-IT] | SwissADME | Soluble |
Blood Brain Barrier permeation | SwissADME | No |
Gastrointestinal absorption | SwissADME | Low |
Log Kp (Skin permeation, cm/s) | SwissADME | -10.92 |
Number of PAINS structural alerts | SwissADME | 0.0 |
Number of Brenk structural alerts | SwissADME | 0.0 |
CYP1A2 inhibitor | SwissADME | No |
CYP2C19 inhibitor | SwissADME | No |
CYP2C9 inhibitor | SwissADME | No |
CYP2D6 inhibitor | SwissADME | No |
CYP3A4 inhibitor | SwissADME | No |
P-glycoprotein substrate | SwissADME | Yes |
Protein identifier | HGNC symbol | Combined score from STITCH database |
---|---|---|
ENSP00000215886 | LGALS2 | 810 |
ENSP00000215909 | LGALS1 | 970 |
ENSP00000236147 | SELL | 826 |
ENSP00000252034 | ELN | 753 |
ENSP00000254301 | LGALS3 | 993 |
ENSP00000258873 | ACSBG1 | 800 |
ENSP00000264162 | LCT | 893 |
ENSP00000264382 | SI | 887 |
ENSP00000267119 | KRT71 | 733 |
ENSP00000302728 | GUSB | 720 |
ENSP00000306920 | GLB1 | 779 |
ENSP00000307240 | KRT74 | 733 |
ENSP00000309576 | LGALS8 | 935 |
ENSP00000315263 | GLTP | 800 |
ENSP00000327070 | MDH2 | 732 |
ENSP00000360829 | GLT6D1 | 794 |
ENSP00000367891 | LGALS7 | 746 |
ENSP00000368119 | GALT | 730 |
ENSP00000378856 | LGALS9 | 957 |
ENSP00000438144 | MDH1 | 784 |